Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Assets Average (2016 - 2025)

Historic Assets Average for Integra Lifesciences Holdings (IART) over the last 16 years, with Q3 2025 value amounting to $3.7 billion.

  • Integra Lifesciences Holdings' Assets Average fell 1014.63% to $3.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 billion, marking a year-over-year decrease of 1014.63%. This contributed to the annual value of $3.9 billion for FY2024, which is 192.48% up from last year.
  • As of Q3 2025, Integra Lifesciences Holdings' Assets Average stood at $3.7 billion, which was down 1014.63% from $3.9 billion recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Assets Average ranged from a high of $4.1 billion in Q2 2024 and a low of $3.7 billion during Q3 2025
  • In the last 5 years, Integra Lifesciences Holdings' Assets Average had a median value of $3.8 billion in 2021 and averaged $3.8 billion.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 937.83% in 2021, then crashed by 1014.63% in 2025.
  • Integra Lifesciences Holdings' Assets Average (Quarter) stood at $3.8 billion in 2021, then increased by 1.85% to $3.8 billion in 2022, then dropped by 2.28% to $3.8 billion in 2023, then rose by 7.74% to $4.1 billion in 2024, then fell by 9.74% to $3.7 billion in 2025.
  • Its Assets Average was $3.7 billion in Q3 2025, compared to $3.9 billion in Q2 2025 and $4.0 billion in Q1 2025.